Free Online Book from PSYPLEXUS - a portal for mental health professionals

Organic mental disorders

AUTHOR: DR. SHAHUL AMEEN, M.D.

Home References
 

5. References

  • Aakerlund LP, Rosenberg J. Postoperative delirium: treatment with supplementary oxygen. Br J Anaesth 1994; 72:286-290.

  • Absher JR, Toole JF. Cerebrovascular disorders. In: Fogel BS, Schiffer RB, Rao SM. Eds. Synopsis of Neuropsychiatry. Philadelphia: Lippincott Williams & Wilkins, 2000, pp. 437-452.

  • Agrawal N. Neuropsychiatry. BMJ Career Focus 2004; 328:s35-s36. 

  • Alexander GE, Crutcher MD, De Long MR. Basal ganglia – thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res 1990; 85:119-146.

  • Alexander MP. Mild traumatic brain injury: pathophysiology, natural history and clinical management. Neurology 1995; 45:1253-1260.

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington DC: APA, 1994.

  • American Psychiatric Association. Practice guidelines for the treatment of patients with delirium. Washington, DC: American Psychiatric Association, 1999.

  • Andersen G. Vestergaard K, Riis J. Citalopram for poststroke pathological crying. Lancet 1993; 342(8875):837-839.

  • Annegers JF, Grabow JD, Kurland, LT, et al. The incidence, causes, and secular trends of head trauma in Olmsted Country, Minnesota, 1935-1974. Neurology 1980; 30:912-919.

  • Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1991; 1:103-116.

  • Askin-Edgar S, White KE, Cummings JL. Neuropsychiatric aspects of Alzheimer’s disease and other dementing illnesses. In: Yudowfsky SE, Hales, RE. Eds. The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. 4th Ed. Washington: American Psychiatric Publishing, Inc., 2002, pp. 953-988.

  • Aykut-Bingol C, Bronen RA, Kim JH, Spencer DD, Spencer SS. Surgical outcome in occipital lobe epilepsy: implications for pathophysiology. Ann Neurol 1998; 44: 60–69.

  • Baines S, Saxby P, Ehlert K. Reality orientation and reminiscence therapy: a controlled cross-over study of elderly confused people. Br J Psychiatry 1987; 151:222-231.

  • Bakchine, S, Lacomblez L, Benoit N, et al. Manic-like state after orbitofrontal and right temporoparietal injury: efficacy of clonidine. Neurology 1989; 39:778-781.

  • Barnes MP, Saunders M, Walls TJ, et al. The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry 1986; 49:991-996.

  • Belyi, BI. Mental impairment in unilateral frontal tumors: role of the laterality of the lesion. Int J Neuro Sci 1987; 32:799-810.

  • Benson DF. Psychiatric aspects of aphasia. Br J Psychiatry 1973; 123:555-566.

  • Berry N, Sagar R, Tripathi BM. Catatonia and other psychiatric symptoms with vitamin B12 deficiency. Acta Psychiatr Scand 2003; 108(2):156-159.

  • Bessette RF, Peterson LG. Fluoxetine and organic mood syndrome. Psychosomatics 1992; 33:224–226.

  • Bien CG, Benninger FO, Urbach H, Schramm J, Kurthen M, Elger CE. Localizing value of epileptic visual auras. Brain 2000; 123 (2): 244-253.

  • Borson S, Raskind MA. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology 1997; 48(5 Suppl 6): S17-24.

  • Breteler MMB, van Duijn CM, Chandra V, et al. Medical history and tehn risk of Alzheimer’s disease: A collaborative reanalysis of case-control studies. Int J Epidemiol 1991; 20:S36-S42.

  • Burke JR, Morgenlander JC. Managing common behavioral problems in dementia: How to improve quality of life for patients and families. Postgrad Med 1999; 106(5):131-134.

  • Burke WJ. Amnestic due to a general medication and amnestic disorder not otherwise specified. In: Gabbard GO. Ed. Treatments of Psychiatric Disorders, 3rd ed. Washington, DC: American Psychiatric Publishing, 2001, pp. 575-588.

  • Burns A, Lewis G, Jacoby R, et al. Factors affecting survival in Alzheimer’s disease. Psychol Med 1991; 21:363–370.

  • Burnside I, Haight B. Reminiscence and life review: therapeutic interventions for older people. Nurse Pract 1994; 19(4):55-61.

  • Byrne EJ. Confusional states in the elderly. Edinburgh: Churchill Livingstone, 1994.

  • Byrne, E. J., Lennox, G., Lowe, J., et al. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52: 709-717.

  • Canadian Study of Health and Aging Working Group: Canadian study of health and aging: Study methods and prevalence of dementia. J Can Med Assoc 1994; 150:899-913.

  • Capwell RR, Carter, R. Organic anxiety syndromes secondary to a metastatic brain tumor. Psychosomatics 1991; 32:231-233.

  • Cascino GD, Adams RD. Brainstem auditory hallucinosis. Neurology 1986; 36:1042-1047.

  • Casey DA, DeFazio Jr JV, Vansickle K, Lippmann SB. Delirium Quick recognition, careful evaluation, and appropriate treatment. Postgrad Med 1996; 100 (1):121-124.

  • Catsman-Berrevoets CE, Van Harskamp F, Applehof A. Beneficial effect of physostigmine on clinical amnesic behavior and neuropsychological test results in a patient with a post-encephalitic amnesic syndrome. J Neurol Neurosurg Psychiatry 1986; 49:1088-1090.

  • Chandra V, Ganguli M, Pandav R, Johnston J, Belle S, DeKosky ST. Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology 1998; 51(4): 1000-1008.

  • Chow TF, Cummings JL. Neuropsychiatry: clinical assessment and approach to diagnosis. In: Sadock BJ, Sadock VA. Eds. Comprehensive Textbook of Psychiatry, Vol, 1, Edn. 7, Baltimore: Williams and Wilkins, 2000, pp. 1169-1198.

  • Chui H, Zhang Q. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology’s practice parameters. Neurology 1997; 49:925-935.

  • Chui H. Vascular dementia, a new beginning. Shifting focus from clinical phenotype to ischemic brain injury. Neurologic Clinics 2000; 18(4):951-977.

  • Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473–480.

  • Clark CM, Karlawish JHT. Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies. Ann Intern Med 2003; 138(5): 400-410.

  • Clark CM, Trojanowski JQ, Lee MYL. Neurofibrillary tangles in Alzheimer’s disease: clinical and pathological implications. In: Brioni JD, Decker MW, Eds. Pharmacological Treatment of Alzheimer’s Disease: Molecular and Neurobiological Foundations. New York: Wiley-Liss, 1997, pp.217-238.

  • Cotman CW, Anderson AJ. Selective vulnerability of the brain to Alzheimer’s disease pathology. In: Clark CM, Trojanowski JQ, Eds. Neurodegenerative Dementias. New York: McGraw-Hill, 2000, 127-130.

  • Cripe LI. The neuropsychological assessment and management of closed head injury: general guidelines. Cognitive Rehabilitation 1987; 5:18–22.

  • Cummings JL, Benson DF. Dementia: A Clinical Approach. Boston, MA: Butterworth, 1992.

  • Cummings JL. Behavioral complications of drug treatment in Parkinson's disease. J Am Geriatr Soc 1991; 39:708-716.

  • Cummings JL. Cholinesterase inhibitors: A new class of psychotropic compounds. Am J Psychiatry 2000; 157:4-15.

  • Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer’s disease. The Tacrine Collaborative Study Group. N Engl J Med 1992; 327:1253-1259.

  • Davison K, Bagley CK. Schizophrenia-like psychosis associated with organic disorder of the CNS. Br J Psychiatry 1969; 4(suppl):113–184.

  • Deb S, Lyons, I, Koutzoukis C, et al. Rates of psychiatric illness 1 year after traumatic brain injury. Am J Psychiatry 1999; 156:374-378.

  • Dikmen, S, Machamer J, Temkin N. Psychosocial outcome in patients with moderate to severe head injury: 2-year follow-up. Brain Inj 1993; 7:113-124.

  • Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1154-1166.

  • Douen AG, Bourque PR. Musical auditory hallucinations from Listeria rhombencephalitis. Can J Neurol Sci 1997; 24:70-72.

  • Drinka TJK, Smith JC, Drinka PJ. Correlates of depression and burden for informal caregivers of patients in a geriatrics referral clinic. J Am Geriatr Soc 1987; 35:522–525.

  • Duffy JD, Campbell JJ. Regional prefrontal syndromes A theoretical and clinical overview. In: Salloway SP, Malloy PF, Duffy JD. Eds: The frontal lobes and neuropsychiatric illness. Washington: American Psychiatric Publishing Inc, 2001, pp 113-123.

  • Eslinger PJ, Geder, L. Behavioral and emotional changes after focal frontal lobe damage. In: Bogousslavsky J, Cummings J. Eds. Behavior and Mood Disorders in Focal Brain Lesions. Cambridge: England University Press, 2000, 217-260.

  • Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons: Higher than previously reported. JAMA 1989; 262:2551-2556.

  • Fann JR, Katon WJ, Uomoto JM. Sertraline in the treatment of depression following mild traumatic brain injury. Presented at the 43rd annual meeting of the Academy of Psychosomatic Medicine, San Antonio, Texas, November 1996.

  • Fann JR. Uomoto JM, Katon WJ. Sertraline in the treatment of MAJOR depression following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci 2000; 12:226-232.

  • Fedoroff JP, Starkstein SE, Forrester AW, et al. Depression in inpatients with acute traumatic brain injury. Am J Psychiatry 1992; 149:918-923.

  • Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217:855–857.

  • Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol 1997; 3:135–197.

  • Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson’s disease. Prevalence, phenomenology and risk factors. Brain 2000; 123: 733–745.

  • Fenton G, McClelland R, Montgomery A, MacFlynn G, Rutherford W. The postconcussional syndrome: social antecedents and psychological sequelae. Br J Psychiatry 1993; 162: 493-497.

  • Filley CM, Kleinschmidt-DeMasters BK. Neurobehavioral presentations of brain neoplasms. West J Med 1995; 163:19-25.

  • Filley CM. The neuroanatomy of attention. Semin Speech Lang 2002; 23:89–98

  • Fleminger S, Burns A. The delusional misidentification syndromes in patients with and without evidence of organic cerebral disorder: a structured review of case reports. Biol Psychiatry 1993; 33:22–32.

  • Folkerts HW, Stadtland C, Reker T. ECT for organic catatonia due to hereditary cerebellar ataxia. J ECT 1998; 14:53-55.

  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.

  • Francis J, Martin D, Kapoor, WN. A prospective study of delirium in hospitalized elderly. Journal of the American Medical Association 1990; 263:1097–1101.

  • French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 1993; 34: 774–780.

  • Gandolfo C, Sugo A, Del Sette M. Sildenafil and transient global amnesia. Neurol Sci 2003; 24(3):145-146.

  • Gao S, Hendrie HC, Hall KS, et al. The relationships between age, sex, and the incidence of dementia and Alzheimer’s disease: A metaanalysis. Arch Gen Psychiatr 1998; 55:809-815.

  • Gauthier S, Advances in the pharmacotherapy of Alzheimer's disease CMAJ 2002; 166 (5), 616-623.

  • Gelenberg AJ. The catatonic syndrome. Lancet 1976; 2:1339-1341.

  • George LK, Gwyther LP. A multidimensional examination of family caregivers of demented adults. Gerontologist 1986; 26:253–259.

  • Gloor P, Olivier A, Quesney LF, Andermann F, Horowitz S. The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982; 12: 129–144.

  • Gómez-Tortosa, E., Newell, K., Irizarry, M. C., et al. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 1999; 53: 1284-1291.

  • Good MI. Substance-induced dissociative disorders and psychiatric nosology.  J Clin Psychopharmacol 1989; 9(2):88-93.

  • Gualiteri CT. Buspirone: neuropsychiatric effects. J Head Trauma Rehabil 1988; 6:90–92.

  • Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974; 2: 207–210.

  • Hammeke TA, Gennarelli TA. Traumatioc brain injury. In: Schiffer RB, Rao SM, Fogel, BS. Eds. Neuropsychiatry. 2nd Edn. Philadelphia: Lippincott Williams & Wilkins, 2003, pp 1149-1167.

  • Hanley IG, McGuire RJ, Boyd WD. Reality orientation and dementia: a controlled trial of two approaches. Br J Psychiatry 1981; 138:10-14.

  • Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125 (2): 391-403. 

  • Haussen-Hauv L, Bancaud J. Gustatory hallucinations in epileptic seizures. Brain 1987; 110:339-359.

  • Hinkeldy NS, Corrigan JD. The structure of head-injured patients' neurobehavioral complaints: preliminary studies. Brain Inj 1990; 4:115–133.

  • Holmes C, Cairns N, Lantos P, et al. Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174: 45–50.

  • Inouye SK. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994; 97: 278-288.

  • International Neuropsychiatric Association. Mission statement. Toronto, Canada: International Neuropsychiatric Association, 1998.

  • Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986; 36:340-345.

  • Jacobson S, Schreibman B. Behavioral and Pharmacologic Treatment of Delirium. Am Fam Physician 1997; 56:2005-2012.

  • Jennett, B. Head injuries in children. Dev Med Child Neurol 1972; 14:137-147.

  • Jennison KM, Johnson KA. Drinking-induced blackouts among young adults: results from a national longitudinal study. Int J Addict 1994; 29(1):23-51.

  • Jones GM. Validation therapy: a companion to reality orientation. Can Nurse 1985; 81(3): 20-23.

  • Jorge RE, Robinson RG, Arndt SV, et al. Comparison between acute and delayed-onset depression following traumatic brain injury. J Neuropsychiatry 1993; 5:43–49.

  • Jorge RE, Robinson RG, Starksein SE, et al. Secondary mania following traumatic brain injury. Am J Psychiatry 1993; 150:916–921.

  • Karli DC, Burke TD, Kim HJ, et al. Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation. Brain Inj 1999; 13:63–68.

  • Kelman HR, Thomas C, Kennedy GJ, et al. Cognitive impairment and mortality in older community residents. Am J Public Health 1994; 84:1255–1260.

  • Keschner M, Vinder MD, Strauss I. Mental symptoms associated with brain tumors: a study of 530 verified cases. JAMA 1938; 110:714-718.

  • Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1143-1153.

  • Kocher R, Linder, M, Stula D. Primary brain tumors in Psychiatry. Schweizer Archiv Fur Neurologie, Neurochirurgie und Psychiatrie 1984; 135:217-227 (Abstract)

  • Kolb LC, Brodie HK. Modern Clinical Psychiatry. Philadelphia: WB Saunders, 1982.

  • Kopelman DM. Amnesic syndromes. In: Gelder MG, Lopez-Ibor JR JJ, Andreasen NC. New Oxford Textbook of Psychiatry New York: Oxford University Press, 2000, pp 454-462.

  • Kraus MF. Neuropsychiatric sequelae of stroke and traumatic brain injury: the role of psychostimulants. Int J Psychiatry Med 1995; 25:39–51.

  • Kraus MF. Neuropsychiatric sequelae: assessment and pharmacologic intervention. In Marion DW. Ed. Traumatic Brain Injury. Vol 14. New York: Thieme Medicine Publishers, 1999, pp 173–185.

  • Kraus, JF, Morgenstern H, Fife D, et al. Blood alcohol tests, prevalence of involvement and outcomes following brain injury. Am J Public Health 1989; 79:294-299.

  • Kukull WA, Brenner DE, Speck CE, et al. Causes of death associated with Alzheimer disease: variation by level of cognitive impairment before death. J Am Gerontol Soc 1994; 42:723–726.

  • Kuzniecky R, Gilliam F, Morawetz R, Faught E, Palmer C, Black L. Occipital lobe developmental malformations and epilepsy: clinical spectrum, treatment, and outcome. Epilepsia 1997; 38: 175–181.

  • Kwentus JA, Hart RP, Peck ET, et al. Psychiatric complications of closed head trauma. Psychosomatics 1985; 26:8–15.

  • Lammli B, Muller A, Ballmer PE. Late sequelae of early summer meningoencephalitis. Schweiz Med Wochenschr 2000; 130(24): 909-915.

  • Launer LJ, AndersenK, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European studies of dementia. Neurology 1999; 52:78-84.

  • Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 1991; 251:675-678.

  • Lesko LM, Fleishman S. Treatment and support in confusional states. Recent Results Cancer Res 1991; 121:378-392.

  • Levin HS, O’Donnell VM, Grossman, RG. The Galveston Orientation and Amnesia Test: A Practical Scale to Assess Cognition after Head Injury. J Nerv Ment Dis 1979; 167:675-684.

  • Levin HS. Memory deficit after closed head injury. In: Boller F, Grafman J. Eds. Handbook of Neuropsychology. Amsterdam: Elsevier, 1989, pp 183-207.

  • Levin HS. Neurobehavioral sequelae of head injury. In Cooper PR. Ed. Head Injury. II Ed. Baltimore: Williams & Wilkins, 1987.

  • Levine DN, Finkelstein S. Delayed psychosis after right temporal–parietal stroke or trauma: relation to epilepsy. Neurology 1982; 32:267–273.

  • Levkoff SE, Liptzin B, Evans DA, Cleary PD, Lipsitz LA, Wettle T, et al. Progression and resolution of delirium in elderly patients hospitalized for acute care. Am J Geriatr Psychiatr 1994; 2: 230-238.

  • Levy ML, Cummings JL, Kahn-Rose R. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontology 1999; 45(Suppl 1):15-22.

  • Lewis L, Athey GI Jr, et al. Psychological treatment of adult psychiatric patients with traumatic frontal lobe injury. J Neuropsychiatry Clin Neurosci 1992; 4:323-330.

  • Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc 1999; 47:564–569.

  • Lindesay J. The concept of delirium. Dement Geriatr Cogn Disord 1999; 10:310–315.

  • Lipowski ZJ. Delirium: acute confusional states. New York: Oxford University Press, 1990.

  • Lishman A. Organic psychiatry. Oxford: Blackwell, 1997.

  • Lishman WA. Brain damage in relation to psychiatric disability after head injury. Br J Psychiatry 1968; 114:373–410.

  • Lishman WA. Physiogenesis and psychogenesis in the post-concussional syndrome. Br J Psychiatry 1988; 153:460–469.

  • Lyketsos C, Rabins PV. Psychopathology in dementia. Curr Opin Psychiatry 1994; 7:342–346.

  • Mace CJ, Trimble MR. Ten-year prognosis of conversion disorder. Br J Psychiatry 1996; 169-282-288.

  • Maeda K, Shirayama Y, Nukina S, Yoshioka S, Kawahara R. Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of 1 patient with risperidone. J Clin Psychiatry 2003; 64(9):1131-1132.

  • Malur C, Pasol E, Francis A. ECT for prolonged catatonia. J ECT 2001; 17:55-59.

  • Marcantonio ER. The management of delirium. In: Lindesay J, Rockwood K, Macdonald A. Eds. The management of delirium in old age. Oxford: Oxford University Press, 2002, 123–152.

  • Mark BZ, Kunkel EJS, Fabi MB, Thompson TL. Pimozide is effective in delirium secondary to hypercalcaemia when other neuroleptics fail. Psychosomatics 1993; 34: 446-450.

  • Martin JB. The Integration of Neurology, Psychiatry, and Neuroscience in the 21st Century. Am J Psychiatry 2002; 159:695-704.

  • Masi G, Mucci M, Floriani C. Acute catatonia after a single dose of ecstasy. J Am Acad Child Adolesc Psychiatry 2002; 41(8):892.

  • Mayberg, HS, Keightley M, Mahurin RK, Brannan, SK. Neuropsychiatric aspects of mood and affective disorders. In: Yudowfsky SE, Hales, RE. Eds. The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. 4th Ed. Washington: American Psychiatric Publishing, Inc., 2002, pp. 1021- 1048.

  • Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 1997; 278: 144-151.

  • McAllister TW. Neuropsychiatric sequelae of head injuries. Psychiatr Clin North Am 1992; 15:395–413.

  • McEntee WJ, Crook, TH. Age-associated memory impairment: a role for catecholamines. Neurology 1990; 40:526-530.

  • McKeith IG, Perry RH, Fairbairn AF, et al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22: 911-922.

  • McKeith IG. Dementia with Lewy bodies. Br J Psychiatry 2002; 180: 144-147.

  • Meagher D. Delirium: the role of psychiatry. Advances in Psychiatric Treatment 2001; 7: 433-442.

  • Meagher DJ. Delirium: optimizing management. BMJ 2001; 322:144-149.

  • Menza MA, Murray GB, Holmes VF, Rafuls WA. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung 1988; 17: 238-241.

  • Menza MA, Murray GB, Holmes VF, Rafuls WA. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48: 278-280.

  • Meyer JS, McClintic KL, Rogers RL, et al. Etiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 1988; 51:1489-1497.

  • Mohs RC, Breitner JCS, Silverman JM, et al. Alzheimer’s disease: morbid risk among first degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatr 1987; 44:405-408.

  • Morris JC, Farlow MR, Ferris SH, Kurz AF, Maelicke A, Rasmusen L, et al. Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers. Clin Ther 2001; 23 (Suppl A):A31-39.

  • Musser WS, Akil M. Clozapine as a treatment for psychosis in Parkinson's disease: a review. J Neuropsychiatry Clin Neurosci 1996; 8:1-9.

  • Narayan M, Nelson JC. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic. J Clin Psychiatry 1997; 58(8):351-354.

  • Nelson EC, Heath AC, Bucholz KK, Madden PA, Fu Q, Knopik V, Lynskey MT, Lynskey MT, Whitfield JB, Statham DJ, Martin NG. Genetic epidemiology of alcohol-induced blackouts. Arch Gen Psychiatry 2004; 61(3):257-263.

  • Nicholas LM, Lindsay BA. Delirium presenting with symptoms of depression. Psychosomatics 1995; 36:471–479.

  • O’Shanick GJ, O’Shanick, AM. Personality and intellectual changes. In: Silver JM, Yudofsky SC, Hales RE. Eds. Neuropsychiatry of traumatic brain injury. Washington, DC: American Psychiatric Press, 1994, 163-188.

  • Ovsiew, F. Bedside neuropsychiatry: Eliciting the clinical phenomena of neuropsychiatric illness. In: Yudowfsky SE, Hales, RE. Eds. The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. 4th Ed. Washington: American Psychiatric Publishing, Inc., 2002, pp. 153-198.

  • Penfield W, Jasper H. Epilepsy and the functional anatomy of the human brain. Boston: Little, Brown, 1954.

  • Peters BH, Levin HS. Memory enhancement after physostigmine treatment in the amnesic syndrome. Arch Neurol 1977; 34:215-219.

  • Plum F. Disorders of the cerebral hemispheres and higher brain functions. In: Berkow R, Fletcher AJ, Eds. The Merck manual of diagnosis and therapy. 16th ed. Rahway, N.J.: Merck Research Laboratories, 1992.

  • Pomeranz HD, Lessell, S. Palinopsia and polyopia in the absence of drugs or cerebral disease. Neurology 2000; 54:855-859.

  • Powell-Proctor L, Miller E. Reality orientation: a critical appraisal. Br J Psychiatry 1982; 140:457-463.

  • Preston GC, Ward CE, Broks P, et al: Effects of lorazepam on memory attention and sedation in man: antagonism by Ro 15-1788. Psychopharmacology 1989; 97:222–227.

  • Price TRP, Goetz KL, Lovell MR. Neuropsychiatric aspects of brain tumors. In: Yudowfsky SE, Hales, RE. Eds. The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. 4th Ed. Washington: American Psychiatric Publishing, Inc., 2002, pp. 753-781.

  • Pruter C, Kunert HJ, Hoff P. ICD-10 mild cognitive disorder following meningitis due to neurosarcoidosis. Psychopathology 2001; 34(6):326-327.

  • Pryse-Phillips W. An olfactory reference syndrome. Acta Psychiat Scand 1971; 47:484-509. 

  • Rao V, Lyketsos CG. Psychiatric aspects of traumatic brain injury. Psychiatr Clin North Am 2002; 25(1):43-69.

  • Reynolds MD, Johnston JM, Dodge H, et al. Small head size is related top small Mini Mental Status examination scores in a community sample of nondemented older adults. Neurology 1999; 53:228-229.

  • Richeimer SH. Psychological intervention in delirium. An important component of management. Postgrad Med 1987; 81(5):173-180.

  • Robichaud L, Hebert R, Desrosiers J. Efficacy of a sensory integration program on behaviors of inpatients with dementia. Am J Occup Ther 1994; 48:355-360.

  • Robillard A, Arts R, Nasreddine Z, Rasmussen L. Efficacy of galantamine in patients not responding to donepezil (18-week interim results). J Neurol Sci 2001; 187(Suppl 1):S59.

  • Robillard A, McKelvey R, Nasreddine Z. Galantamine improves sleep in patients withdrawn from donepezil (prelminary results). J Neurol Sci 2001; 187(Suppl 1):S55.

  • Robinson RG, Boston JD, Starkstein SE, et al: Comparison of mania and depression after brain injury: causal factors. Am J Psychiatry 1988; 145:172–178.

  • Robinson RG, Parikh RM, Lipsey JR, et al. Pathological laughing and crying following stroke: validation of measurement scale and double-blind treatment study. Am J Psychiatry 1993; 150:286-293.

  • Robinson RG, Travella JI, Conwell Y, Henderson RE. Mood disorders and suicide. In: Fogel BS, Schiffer RB, Rao SM. Eds. Synopsis of Neuropsychiatry.  Philadelphia: Lippincott Williams & Wilkins, 2000, pp 289-311.

  • Robinston RG, Starkstein SE. Neuropsychiatric aspects of cerebrovascular disorders. In: Yudowfsky SE, Hales, RE. Eds. The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. 4th Ed. Washington: American Psychiatric Publishing, Inc., 2002, pp. 723-752.

  • Rockwood K, Cosway S, Stolee P, et al. Increasing the recognition of delirium in elderly patients. J Am Geriatr Soc 1994; 42:252–256.

  • Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Donepezil Study Group. Neurology 1998; 50:136-145.

  • Rolfson D. The causes of delirium. In: Lindesay J, Rockwood K, Macdonald A, Eds. Delirium in the elderly. Oxford: Oxford University Press, 2002, pp. 101–122.

  • Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–260.

  • Rommel O, Tegenthoff M, Widdig W, et al. Organic catatonia following frontal lobe injury: Response to clozapine. J Neuropsychiastry Clin Neurosci 1998; 10:237-238.

  • Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980; 7: 486–488.

  • Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, et al. Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomized controlled trial. BMJ 1999; 318:633-638.

  • Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998; 64:588-594.

  • Royall DR, Mahurin RK, Gray KF. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc. 1992; 40:1221-1226.

  • Rudberg MA, Pompei P, Foreman MD, Ross RE, Cassel CK. The natural history of delirium in older hospitalized patients: a syndrome of heterogeneity. Age Ageing 1997; 26: 169-175.

  • Ruedrich SL, Chu CC, Moore SL. ECT for major depression in a patient with acute brain trauma. Am J Psychiatry 1983; 140:928–929.

  • Sabshin M. Turning points in twentieth-century American psychiatry. Am J Psychiatry 1990; 147: 1267-1264.

  • Sanders KM, Cassem EH. Psychiatric complications in the critically ill cardiac patient. Tex Heart Inst J 1993; 20: 180-187.

  • Santhouse AM, Howard RJ, Ffytche, DJ. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 2000; 123 (10): 2055-2064.

  • Schenk L, Bear, D. Multiple personality and related dissociative phenomena in patients with temporal lobe epilepsy. Am J Psychiatry 1981; 138:1311-1316.

  • Schmidley JW, Messing Y. Agitated confusional states in patients with right hemisphere infarctions. Stroke 1984; 15:883–885.

  • Schofield I. A small exploratory study of the reaction of older people to an episode of delirium. J Adv Nurs 1997; 25: 942-952.

  • Schreiber S, Klag E, Gros Y, et al. Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury. Int Clin Psychopharmacol 1998; 13:273-275.

  • Shankle WR, Nielson KA, Cotman CW. Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients. Alzheimer Dis Assoc Disord 1995; 9(4):233-237.

  • Silver JM, Yudofsky, SC. Psychopharmacology. In:  Silver JM, Yudofsky SC, Hales RE. Eds. Neuropsychiatry of traumatic brain injury. Washington, DC: American Psychiatric Press, 1994, 631-670.

  • Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics 1998; 39: 422-430.

  • Sipahimalani A, Sime R, Masand P. Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1997; 1: 24-26.

  • Sirois F. Delirium: 100 cases. Canadian Journal of Psychiatry 1988; 33:375–378.

  • Slater E. Diagnosis of hysteria. BMJ 1965; 1:1395-1399.

  • Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA 1997; 278:1363-1371.

  • Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997; 278(16):1363-1371.

  • Sparks DL, Hunsaker JCI, Scheff SW, et al. Cortical senile plaques in coronary artery disease, aging, and Alzheimer’s disease. Neurobiol Aging 1990; 11:601-607.

  • Starksein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987; 110:1045–1059.

  • Starkstein SE, Fedoroff JP, Berthier, MD, et al. Manic depressive and pure manic states after brain lesions. Biol Psychiatry 1991; 29:149-158.

  • Starkstein SE, Robinson, RG. Depression in neurologic disease. Baltimore: Johns Hopkins University Press, 1993.

  • Stewart JT. Leadon M, Gonzalez-Rothi LJ. Treatment of a case of akinetic mutism with bromocriptine. J Neuropsychiatry Clin Neurosci 1990; 2:462-463.

  • Swartz, CM. Delirium or catatonic disorder due to general medical condition. J ECT 2002; 18:167-168.

  • Szucs A, Janszky J, Hollo A, Migleczi G, Halasz P. Misleading hallucinations in unrecognized narcolepsy. Acta Psychiatr Scand. 2003; 108(4):314-316.

  • Tariot PN, Erb R, Podgorski CA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998; 155(1):54-61.

  • Taverni JP, Seligei G, Lichtman SW. Donepezil-mediated memory improvement in traumatic brain injury during post-acute rehabilitation. Brain Inj 1998; 12:77–80.

  • Tennant FS. Naltrexone treatment for PCS. Am J Psychiatry 1987; 144:813–814.

  • Trockman G. Caring for the confused or delirious patient. Am J Nurs 1978; 78:1495-1499.

  • Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000; 5:132–148.

  • Tyrone AO, Fernandez JM. Dissociative disorder associated with a colloid cyst of the third ventricle: organic or psychogenic amnesia? Psychother Psychosom 2000; 69:108-`09.

  • Ullrich NJ, Urion DK. Transient global amnesia in a young adult with cyanotic heart disease. Pediatr Neurol 2003; 29(4):334-336.

  • Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. Philadelphia: F.A. Davis, 1971.

  • Walburg FL, Zeigler DK. Olfactory hallucinations in migraine. Arch Neurol 1982; 39:382.

  • Weiner, M. F. Dementia associated with Lewy bodies. Arch Neurol 1999; 56, 1441-1442.

  • Weiss G, Hechtman L. Hyperactive children grown up. 2nd Ed. New York: Guilford Press, 1993.

  • Wengel SP, Roccaforte WH, Burke WJ. Donepezil improves symptoms of delirium in dementia: implications for future research. J Geriatr Psychiatry Neurol 1998; 11:159–161.

  • Whitlock, FA. The Ganser syndrome. Br J Psychiatry 1967; 113:19-29.

  • Wilcock GK, Whitehead A, Evans JG, Birks J, Perdomo C, Pratt RD. Donepezil: a meta-analysis of individual patient's data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease. Neurology 2001; 56(Suppl 3):A339.

  • Wilson BA. Cognitive rehabilitation: how it is and how it might be. J Int Neuropsychol Soc 1997; 3:487–496.

  • Wisniewsky KE, Wisniewsky HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol 1985; 17:278-282.

  • Wolff HG, Curran D. Nature of delirium and allied states. Arch Neurol Psychiatr 1935; 33:1175-1215.

  • Wolters EC, Jansen ENH, Tuynman-Qua HG, Bergmans PLM. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology 1996; 47:1085-1087.

  • Woods P, Ashley J. Simulated presence therapy: using selected memories to manage problem behaviors in Alzheimer's disease patients. Geriatr Nurs 1995; 16(1):9-14.

  • World Health Organization. The ICD–10 Classification of Mental and Behavioural Disorders. Geneva: WHO, 1992

  • Wrobleski BA, Joseph AV, Cornblatt RR. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled prospective study. J Clin Psychiatry 1996; 57:582-587.

  • Yudofsky SC, Hales RE. Delirium, dementia, and amnestic and other cognitive disorders. In: Gabbard GO. Ed. Treatments of Psychiatric Disorders. 3rd Ed. Washington, DC: American Psychiatric Publishing, 2001, pp. 383-386.

Back to Top